Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis

Kyung Ho Choi, Bong Lee Eun, Dal Yoo Chang, Joo Baek Han, Wook Kang Seong, Chul Shin Ki, Jong Lee Yun, Ah Kim Hyun, Ju Hong Jeon, Chai Wan Kim, Dong Myung Shin, In Gyu Kim, Wook Song Yeong

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Filaggrin is expressed in the cornified layer of epidermis and known to be one of the antigenic targets in rheumatoid arthritis. Although the citrulline residue in filaggrin is thought to be an antigenic determinant recognized by autoantibodies, the diagnostic sensitivity of synthetic citrullinated peptide is variable. To investigate the implication of anti-filaggrin antibodies recognizing uncitrullinated filaggrin in rheumatoid arthritis, we assayed antibody titers using unmodified recombinant filaggrin in the sera from 73 patients with rheumatoid arthritis, 150 patients with other connective tissue diseases and 70 normal controls. We also performed the correlation analysis between antibody titers and the clinical variables in patients with rheumatoid arthritis. Titers of IgG anti-filaggrin antibodies were significantly higher in rheumatoid arthritis patients compared to normal controls (P = 0.02), but not in patients with osteoarthritis, ankylosing spondylitis or systemic lupus erythematosus. IgG anti-filaggrin antibodies were more frequently found in patients with rheumatoid arthritis compared to normal controls (12.3% vs 1.4% respectively, P = 0.04). An anti-filaggrin antibody titer was correlated with visual analogue scale of pain, tender joint count, Ritchie articular index or C-reactive protein, but not with anti-nuclear antibody or rheumatoid factor. These results suggest that anti-filaggrin antibody recognizes the uncitrullinated filaggrin as an antigen and its titer correlates with clinical parameters, explaining the variable sensitivity of anti-filaggrin antibody test.

Original languageEnglish (US)
Pages (from-to)546-552
Number of pages7
JournalExperimental and Molecular Medicine
Volume37
Issue number6
StatePublished - Dec 31 2005

Fingerprint

Anti-Idiotypic Antibodies
Rheumatoid Arthritis
Antibodies
filaggrin
Immunoglobulin G
Joints
Citrulline
Connective Tissue Diseases
Rheumatoid Factor
Ankylosing Spondylitis
Pain Measurement
Epidermis
Osteoarthritis
Systemic Lupus Erythematosus
C-Reactive Protein
Autoantibodies
Epitopes
Tissue
Antigens
Peptides

Keywords

  • Autoimmune
  • Cyclin citrullinated peptide
  • Diseases
  • Filaggrin
  • Immunoenzyme techniques
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Biochemistry
  • Genetics

Cite this

Choi, K. H., Eun, B. L., Chang, D. Y., Han, J. B., Seong, W. K., Ki, C. S., ... Yeong, W. S. (2005). Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis. Experimental and Molecular Medicine, 37(6), 546-552.

Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis. / Choi, Kyung Ho; Eun, Bong Lee; Chang, Dal Yoo; Han, Joo Baek; Seong, Wook Kang; Ki, Chul Shin; Yun, Jong Lee; Hyun, Ah Kim; Jeon, Ju Hong; Kim, Chai Wan; Shin, Dong Myung; Kim, In Gyu; Yeong, Wook Song.

In: Experimental and Molecular Medicine, Vol. 37, No. 6, 31.12.2005, p. 546-552.

Research output: Contribution to journalArticle

Choi, KH, Eun, BL, Chang, DY, Han, JB, Seong, WK, Ki, CS, Yun, JL, Hyun, AK, Jeon, JH, Kim, CW, Shin, DM, Kim, IG & Yeong, WS 2005, 'Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis', Experimental and Molecular Medicine, vol. 37, no. 6, pp. 546-552.
Choi, Kyung Ho ; Eun, Bong Lee ; Chang, Dal Yoo ; Han, Joo Baek ; Seong, Wook Kang ; Ki, Chul Shin ; Yun, Jong Lee ; Hyun, Ah Kim ; Jeon, Ju Hong ; Kim, Chai Wan ; Shin, Dong Myung ; Kim, In Gyu ; Yeong, Wook Song. / Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis. In: Experimental and Molecular Medicine. 2005 ; Vol. 37, No. 6. pp. 546-552.
@article{61788367ec324618a441e1e2eb9e85ee,
title = "Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis",
abstract = "Filaggrin is expressed in the cornified layer of epidermis and known to be one of the antigenic targets in rheumatoid arthritis. Although the citrulline residue in filaggrin is thought to be an antigenic determinant recognized by autoantibodies, the diagnostic sensitivity of synthetic citrullinated peptide is variable. To investigate the implication of anti-filaggrin antibodies recognizing uncitrullinated filaggrin in rheumatoid arthritis, we assayed antibody titers using unmodified recombinant filaggrin in the sera from 73 patients with rheumatoid arthritis, 150 patients with other connective tissue diseases and 70 normal controls. We also performed the correlation analysis between antibody titers and the clinical variables in patients with rheumatoid arthritis. Titers of IgG anti-filaggrin antibodies were significantly higher in rheumatoid arthritis patients compared to normal controls (P = 0.02), but not in patients with osteoarthritis, ankylosing spondylitis or systemic lupus erythematosus. IgG anti-filaggrin antibodies were more frequently found in patients with rheumatoid arthritis compared to normal controls (12.3{\%} vs 1.4{\%} respectively, P = 0.04). An anti-filaggrin antibody titer was correlated with visual analogue scale of pain, tender joint count, Ritchie articular index or C-reactive protein, but not with anti-nuclear antibody or rheumatoid factor. These results suggest that anti-filaggrin antibody recognizes the uncitrullinated filaggrin as an antigen and its titer correlates with clinical parameters, explaining the variable sensitivity of anti-filaggrin antibody test.",
keywords = "Autoimmune, Cyclin citrullinated peptide, Diseases, Filaggrin, Immunoenzyme techniques, Rheumatoid arthritis",
author = "Choi, {Kyung Ho} and Eun, {Bong Lee} and Chang, {Dal Yoo} and Han, {Joo Baek} and Seong, {Wook Kang} and Ki, {Chul Shin} and Yun, {Jong Lee} and Hyun, {Ah Kim} and Jeon, {Ju Hong} and Kim, {Chai Wan} and Shin, {Dong Myung} and Kim, {In Gyu} and Yeong, {Wook Song}",
year = "2005",
month = "12",
day = "31",
language = "English (US)",
volume = "37",
pages = "546--552",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "6",

}

TY - JOUR

T1 - Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis

AU - Choi, Kyung Ho

AU - Eun, Bong Lee

AU - Chang, Dal Yoo

AU - Han, Joo Baek

AU - Seong, Wook Kang

AU - Ki, Chul Shin

AU - Yun, Jong Lee

AU - Hyun, Ah Kim

AU - Jeon, Ju Hong

AU - Kim, Chai Wan

AU - Shin, Dong Myung

AU - Kim, In Gyu

AU - Yeong, Wook Song

PY - 2005/12/31

Y1 - 2005/12/31

N2 - Filaggrin is expressed in the cornified layer of epidermis and known to be one of the antigenic targets in rheumatoid arthritis. Although the citrulline residue in filaggrin is thought to be an antigenic determinant recognized by autoantibodies, the diagnostic sensitivity of synthetic citrullinated peptide is variable. To investigate the implication of anti-filaggrin antibodies recognizing uncitrullinated filaggrin in rheumatoid arthritis, we assayed antibody titers using unmodified recombinant filaggrin in the sera from 73 patients with rheumatoid arthritis, 150 patients with other connective tissue diseases and 70 normal controls. We also performed the correlation analysis between antibody titers and the clinical variables in patients with rheumatoid arthritis. Titers of IgG anti-filaggrin antibodies were significantly higher in rheumatoid arthritis patients compared to normal controls (P = 0.02), but not in patients with osteoarthritis, ankylosing spondylitis or systemic lupus erythematosus. IgG anti-filaggrin antibodies were more frequently found in patients with rheumatoid arthritis compared to normal controls (12.3% vs 1.4% respectively, P = 0.04). An anti-filaggrin antibody titer was correlated with visual analogue scale of pain, tender joint count, Ritchie articular index or C-reactive protein, but not with anti-nuclear antibody or rheumatoid factor. These results suggest that anti-filaggrin antibody recognizes the uncitrullinated filaggrin as an antigen and its titer correlates with clinical parameters, explaining the variable sensitivity of anti-filaggrin antibody test.

AB - Filaggrin is expressed in the cornified layer of epidermis and known to be one of the antigenic targets in rheumatoid arthritis. Although the citrulline residue in filaggrin is thought to be an antigenic determinant recognized by autoantibodies, the diagnostic sensitivity of synthetic citrullinated peptide is variable. To investigate the implication of anti-filaggrin antibodies recognizing uncitrullinated filaggrin in rheumatoid arthritis, we assayed antibody titers using unmodified recombinant filaggrin in the sera from 73 patients with rheumatoid arthritis, 150 patients with other connective tissue diseases and 70 normal controls. We also performed the correlation analysis between antibody titers and the clinical variables in patients with rheumatoid arthritis. Titers of IgG anti-filaggrin antibodies were significantly higher in rheumatoid arthritis patients compared to normal controls (P = 0.02), but not in patients with osteoarthritis, ankylosing spondylitis or systemic lupus erythematosus. IgG anti-filaggrin antibodies were more frequently found in patients with rheumatoid arthritis compared to normal controls (12.3% vs 1.4% respectively, P = 0.04). An anti-filaggrin antibody titer was correlated with visual analogue scale of pain, tender joint count, Ritchie articular index or C-reactive protein, but not with anti-nuclear antibody or rheumatoid factor. These results suggest that anti-filaggrin antibody recognizes the uncitrullinated filaggrin as an antigen and its titer correlates with clinical parameters, explaining the variable sensitivity of anti-filaggrin antibody test.

KW - Autoimmune

KW - Cyclin citrullinated peptide

KW - Diseases

KW - Filaggrin

KW - Immunoenzyme techniques

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=31344461281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344461281&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 546

EP - 552

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 6

ER -